Continuous Vision Cipher Surgical’s OpClear platform provides continuous intra-abdominal visualization during laparoscopic procedures, using automated CO2 flow and on-demand saline lens wash to minimize scope removals. It rapidly clears fogging, misting and debris from energy plumes, enabling ongoing visibility. This can help surgical teams reduce errors and shorten operating times, making it attractive to hospitals and ambulatory surgery centers seeking efficiency and patient-safety ROI.

Funding Backing Recent Series A financing of 10 million USD (April 2025) signals investor confidence and provides a runway to scale manufacturing, distribution, and clinical adoption. This momentum can help accelerate pilots, expand downstream partnerships with OEMs or medical distributors, and broaden market access in competitive laparoscopic markets.

Leadership Growth Leadership change with Mark Alley appointed CEO in March 2024 suggests a strategic push toward commercial scaling and go-to-market execution. Engage directly with the executive team on adoption timelines, pilot programs, and hospital procurement cycles to align sales efforts with company growth plans.

Regulatory Quality ISO 13485 certification highlights strong quality management for medical devices, reducing procurement risk for health systems and smoothing audits and regulatory expectations. This can be a selling point when engaging with hospitals and GPOs focused on supplier quality and post-market support.

Channel Partnerships Small company size paired with modern digital tools positions Cipher Surgical for channel partnerships and rapid market entry. Explore collaboration with larger laparoscopic equipment makers or distributors to leverage established sales networks, while leveraging digital channels (PWA, web demos) to reach surgeons and procurement teams with demonstrable ROI.